ContributorsPublishersAdvertisers

Bristol Myers Squibb granted EU recommendation for CAR T therapy in lymphoma

Seeking Alpha
Seeking Alpha
 2022-01-28
Cover picture for the article

Bristol Myers Squibb (NYSE:BMY) announced that an expert panel of the European Medicines Agency (EMA) recommended its chimeric antigen receptor (CAR) T cell therapy, Breyanzi, as a treatment for three forms of lymphoma. Accordingly, Breyanzi is expected to be...

seekingalpha.com

Comments / 0

Comments / 0